- Home
- NC vs AQST Comparison
NC vs AQST Comparison
Compare NC & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NC
- AQST
- Stock Information
- Founded
- NC 1913
- AQST 2004
- Country
- NC United States
- AQST United States
- Employees
- NC N/A
- AQST N/A
- Industry
- NC Coal Mining
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- NC Energy
- AQST Health Care
- Exchange
- NC Nasdaq
- AQST Nasdaq
- Market Cap
- NC 247.6M
- AQST 254.1M
- IPO Year
- NC N/A
- AQST 2018
- Fundamental
- Price
- NC $36.85
- AQST $2.51
- Analyst Decision
- NC
- AQST Strong Buy
- Analyst Count
- NC 0
- AQST 6
- Target Price
- NC N/A
- AQST $11.17
- AVG Volume (30 Days)
- NC 19.4K
- AQST 1.4M
- Earning Date
- NC 04-30-2025
- AQST 05-06-2025
- Dividend Yield
- NC 2.46%
- AQST N/A
- EPS Growth
- NC N/A
- AQST N/A
- EPS
- NC 4.55
- AQST N/A
- Revenue
- NC $237,708,000.00
- AQST $57,561,000.00
- Revenue This Year
- NC N/A
- AQST N/A
- Revenue Next Year
- NC N/A
- AQST $39.51
- P/E Ratio
- NC $8.10
- AQST N/A
- Revenue Growth
- NC 10.67
- AQST 13.79
- 52 Week Low
- NC $25.19
- AQST $2.20
- 52 Week High
- NC $39.65
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- NC 62.28
- AQST 41.88
- Support Level
- NC $34.35
- AQST $2.20
- Resistance Level
- NC $37.97
- AQST $2.61
- Average True Range (ATR)
- NC 1.90
- AQST 0.22
- MACD
- NC 0.35
- AQST -0.03
- Stochastic Oscillator
- NC 70.98
- AQST 36.47
About NC NACCO Industries Inc.
NACCO Industries Inc is a holding company that operates in the mining and natural resource industries. It has three operating segments that are coal mining, North American mining (NA mining), and minerals management. The majority of its revenue is from the coal mining segment. This segment operates surface coal mines under long-term contracts with power generation companies and an activated carbon producer pursuant to a service-based business model. The NA mining segment provides value-add contract mining and services for producers. Minerals management generates income from royalty-based leases by acquiring and promoting oil, gas, and coal mineral interests. The company is diversifying beyond coal mining due to political and economic pressures associated with carbon emissions.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.